Thorp Clay

Director | Director, 10% Owner

1 company

Good

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+10.1%

Avg 12M Return

+19.4%

Thorp Clay is a Director at Clearside Biomedical, Inc.. Recent SEC Form 4 filings include 4 buys and 15 sells.

Estimated insider holdings value: $56K based on current market prices.

Holdings by Company

CLSDQFeb 24, 2025

Current Shares176.1K

Value$56.4K

Net Activity+3.3K

Bought: 832.7KSold: 829.4K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 24, 2025	CLSDQ Clearside Biomedical, Inc.	Director	Buy	15,000	$0.92	$13,800.00	+9.3%	-6.9%	-
Sep 25, 2023	CLSDQ Clearside Biomedical, Inc.	Director	Buy	10,000	$0.86	$8,600.00	+32.8%	+35.3%	+34.7%
Dec 21, 2022	CLSDQ Clearside Biomedical, Inc.	Director	Buy	14,000	$1.02	$14,266.00	+84.7%	+2.0%	+4.0%
Feb 10, 2021	CLSDQ Clearside Biomedical, Inc.	Director	Sell	32,873	$4.43	$145,627.39	-0.9%	-	-
Dec 6, 2018	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Buy	8,000	$1.36	$10,880.00	New	-	-
May 18, 2018	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	161,139	$13.08	$2,107,589.24	-2.3%	-	-
Mar 23, 2018	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	138,861	$12.21	$1,695,790.72	-1.3%	-	-
Dec 7, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	35,000	$6.22	$217,550.00	-0.3%	-	-
Nov 16, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	35,000	$7.00	$245,100.00	-0.3%	-	-
Oct 5, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	35,000	$8.57	$299,900.00	-0.3%	-	-